Maziar Mike Doustdar is the Chief Executive Officer and President of Novo. Maziar has held the CEO seat since August 2025.
Current company
Novo
Novo is a Danish pharmaceutical company.
pharmaceutical industryHeadquartered in BagsværdFounded 1923NYSE: NVO
Source: WikidataMaziar Mike Doustdar joined Novo Nordisk in June 1992 and has been CEO since August 2025.
Career
Sources: LinkedIn profile
Education
Harvard Business School, Executive Education, Leadership in Pharmaceutical & BiotechWebster Vienna Private University, B.A., MarketingPrimary schoolSource
960+ decision makers at Novo in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Novo
Vice president level and above, most senior firstMaziar Mike Doustdar leads a leadership team of 11 published executives. The most recent appointment is Jamey Millar as Executive vice president, US Operations, in seat since February 2026.
Most senior 5 of 11
| Name | Title | In seat since |
|---|---|---|
| Maziar Mike Doustdar | President and chief executive officer (CEO) | August 2025 |
| Elin Jäger | Senior vice president, chief of staff to CEO; Corporate Strategy & Sustainability | September 2025 |
| Karsten Munk Knudsen | Executive vice president and chief financial officer (CFO) | February 2018 |
| Martin Holst Lange | Executive vice president, R&D and chief scientific officer (CSO) | August 2025 |
| John F. Kuckelman | Senior vice president, Group General Counsel, Global Legal, IP and Security | 2024 |
Sources: Novo 2025 Form 20-F
Maziar Mike Doustdar is the Chief Executive Officer and President of Novo. Maziar has held the CEO seat since August 2025.
Maziar Mike Doustdar has been CEO of Novo since August 2025, according to LinkedIn profile.
Maziar Mike Doustdar has been CEO of Novo for 1 year, since August 2025.
Elin Jäger (Senior vice president, chief of staff to CEO; Corporate Strategy & Sustainability), Karsten Munk Knudsen (Executive vice president and chief financial officer (CFO)), Martin Holst Lange (Executive vice president, R&D and chief scientific officer (CSO)), John F. Kuckelman (Senior vice president, Group General Counsel, Global Legal, IP and Security), and 6 more. Source: Novo 2025 Form 20-F.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.
